Instrument Fundamentals
| Date | Close | Change | Change (%) | Open | High | Low |
|---|
News
Bristol Myers Squibb Company $BMY Stock: Banco Santander S.A. Decreases Stake
We are open to external innovation and collaborations in India: BMS EVP Cristian Massacesi
Bristol Myers Squibb Company $BMY Stock: Patrick Mauro Investment Advisor INC. Decreases Stake - Daily Political
Bristol Myers Squibb Company (NYSE:BMY) Stock Rated "Hold" by Wall Street Brokerages
Bristol Myers Squibb (BMY) Stock Could Be Undervalued On Cash Flow
How Investors Are Reacting To Bristol Myers Squibb (BMY) R&D Leadership Overhaul
How Many Shares of Pfizer, Merck or Bristol Myers Squibb Pay $1,000 a Month in Dividends?
3 Defensive Dividend Stocks for Retirees Worried About the Next Market Downturn
4 Healthcare Dividend Stocks for Retirees. One Yields Over 4%
Schrodinger Eyes Growth From AI Assistant Bunsen and Hosted Software Shift - Stock Observer
A Record-High Dividend Yield Can Be a Warning Sign. Just Ask Pfizer
Have Insiders Sold Bristol-Myers Squibb Shares Recently?
FY2026 EPS Forecast for Bristol Myers Squibb Cut by Analyst
Bristol Myers Squibb Company $BMY Stock Bought by PBU The Pension Fund of Early Childhood & Youth Educators - Zolmax
Eurizon Capital SGR S.p.A. Sells 240,580 Shares of Bristol Myers Squibb Company $BMY - Zolmax
Bristol Myers Squibb Company $BMY Stock: Eurizon Capital SGR S.p.A. Cuts Stake - Daily Political
Bristol Myers Squibb (BMY) Stock Looks Below Fair Value Following A 41% Run
Bristol Myers research chief to depart in 'evolution' of company's structure
Bristol Myers to Unite R&D Organization Under Cristian Massacesi | Morningstar
Bristol Myers to merge scientific, clinical teams under new R&D structure - Yahoo News Malaysia
Bristol Myers Squibb Company $BMY Stock Holdings Increased by King Luther Capital Management Corp - Stock Observer
Bristol Myers Squibb Company $BMY Position Cut by Keybank National Association OH - Daily Political
Effect of two common GVHD prophylaxis regimens on the gut microbiome in a randomized phase 3 trial
Americans Fill Prescriptions Every Month, and $90,000 Across These 3 Drugmakers Pays $3,650 a Year
Bristol Myers Squibb (NYSE:BMY) Share Price Crosses Above 50-Day Moving Average - Here's Why
Normalized membrane ratio of TROP2 as a predictor of clinical outcomes with datopotamab deruxtecan in non-small-cell lung cancer
Bristol Myers Squibb Company $BMY Shares Bought by Allspring Global Investments Holdings LLC
Bristol Myers Squibb Company $BMY Stake Trimmed by M&G PLC - Stock Observer
Bristol Myers Squibb (BMY), What Is Behind Its Latest Update?
5 Defensive Dividend Stocks Yielding Up to 8.7% for Retirement Income
M Holdings Securities Inc. Buys 45,082 Shares of Bristol Myers Squibb Company $BMY
BMS's Camzyos shows continued benefit in paediatric oHCM at 56 weeks
The Leukemia Therapeutics Market is estimated to reach USD 31.43 billion by 2034, witnessing a CAGR of 6.6% throughout the forecast period.
Bristol Myers Squibb Company $BMY Stock Sold by CenterBook Partners LP
Bristol Myers Squibb Company $BMY Shares Bought by Pictet Asset Management Holding SA - Stock Observer
Does Growth Drug Sales Change The Bull Case For Bristol Myers Squibb Stock?
Bristol Myers Squibb Company $BMY Stock: Kestra Advisory Services LLC Raises Position - Daily Political
An ulcerative colitis taxonomy defined by individual patient-reported response trajectories
Bristol Myers Squibb Company $BMY Position Lifted by Avantax Planning Partners Inc.
Bristol Myers Squibb Company $BMY Shares Purchased by Avantax Planning Partners Inc.
Bristol Myers Squibb Company $BMY Holdings Lifted by Ethic Inc.
22,500 Bristol Myers Squibb Company $BMY Shares Sold by Axiom Investment Management LLC
Bristol Myers Squibb Company $BMY Shares Sold by Commonwealth Equity Services LLC
Analyzing Prothena (NASDAQ:PRTA) & Century Therapeutics (NASDAQ:IPSC) - Markets Daily
Bristol Myers Squibb Company $BMY Stock Purchased by Candriam S.C.A. - Daily Political
Bristol Myers Squibb Company $BMY Stake Cut by United Advisor Group LLC - Daily Political
Bristol Myers Squibb Company $BMY Stock Bought by Alps Advisors Inc.
Has Bristol-Myers Squibb (BMY) Moved Above Fair Value After A 41% Gain?
Bristol Myers Squibb (NYSE:BMY) Director Julia Haller Sells 3,800 Shares of Company Stock
Bristol Myers Squibb Yields Over 4%. Can Its Dividend Survive 2027?
Bristol Myers Squibb (NYSE:BMY) Director Sells $240,578.00 in Stock - Stock Observer
Critical Analysis: Bristol Myers Squibb (BMY) versus Its Competitors
What Halozyme Therapeutics (HALO) Said on Its Q3 Earnings Call
Bristol Myers Squibb Company $BMY Stock: Pzena Investment Management LLC Lowers Holdings
Bristol Myers Squibb Company $BMY Shares Sold by AIA Group Ltd
48,234 Shares in Bristol Myers Squibb Company $BMY Acquired by Associated Banc Corp
An information-theoretic framework for inferring T cell dynamics from single-cell RNA and T cell receptor sequencing
Bristol Myers Squibb Canada Partners with TANK Worldwide and Ogilvy Health to Turn Autumn Leaves into a Guide for Spotting the Warning Signs of Melanoma
Head-To-Head Contrast: Bristol Myers Squibb (BMY) & Its Peers - Zolmax
Bristol Myers Squibb Company $BMY Stock Holdings Raised by Rakuten Investment Management Inc.
Bristol Myers Squibb Shares Rose Even As Profit Fell
Bausch Health Cos (NYSE:BHC) & Bristol Myers Squibb (NYSE:BMY) Head-To-Head Comparison - Markets Daily
Analyzing Bristol Myers Squibb (NYSE:BMY) and Bausch Health Cos (NYSE:BHC) - Stock Observer
Why Tempus AI Stock Is Up 8.7% And What's Next
Bristol Myers Squibb Company $BMY Shares Newly Purchased by VCI Wealth Management LLC
Bristol Myers Squibb (NYSE:BMY) Stock Price Breaks Above 50 Day Moving Average on Analyst Downgrade - Stock Observer
Reply to: 'Interpreting surgical consolidation in oligometastatic gastro-oesophageal cancer'
Regulatable membrane-bound IL-15 engineered TIL cell therapy for immune checkpoint inhibitor-resistant advanced melanoma: pooled analysis of phase 1 and 1/2 trials
5 must-read analyst questions from Bristol-Myers Squibb's Q3 earnings call
TEM Stock Jumps On Upbeat Revenue, Raised Outlook - Cathie Wood's ARK Buys Over 154K Shares Ahead Of Earnings
43 ETFs Add to Bristol-Myers Squibb (BMY) on Oct. 29
Bank Julius Baer & Co. Ltd Zurich Purchases 73,200 Shares of Bristol Myers Squibb Company $BMY
18,717 Bristol Myers Squibb Company $BMY Shares Purchased by Profund Advisors LLC - Stock Observer
Bristol Myers Squibb (NYSE:BMY) Stock Gets Price Target Trim from Morgan Stanley - Zolmax
Bristol Myers Squibb Company $BMY Stock: Heritage Investors Management Corp Cuts Position - Daily Political
Learn Why The Bull Case For Bristol Myers Squibb Stock Could Change Following Earnings Beat
Molecular and immune heterogeneity across limited-stage and extensive-stage small cell lung cancer
Denosumab in multiple myeloma patients with severe renal impairment: a multicenter phase 2 study
Povorcitinib for nonsegmental vitiligo: two randomized, controlled, phase 3 STOP-V trials
Mirae Asset Global Investments Co. Ltd. Makes New Investment in Bristol Myers Squibb Company $BMY
Sumitomo Mitsui Trust Group Inc. Sells 19,128 Shares of Bristol Myers Squibb Company $BMY - Daily Political
Hengrui's third-quarter profit rebounds on out-licensing revenue
Why Everyone Is Watching Bristol-Myers Squibb (BMY) Today
What Bristol Myers Squibb Stock's Earnings Beat Means For Shareholders
Bristol Myers Squibb (NYSE:BMY) Posts Earnings Results, Beats Expectations By $0.25 EPS - Stock Observer
Bristol Myers Squibb Company $BMY Stock Bought by Americana Partners LLC - Markets Daily
Bristol Myers Squibb Company $BMY Shares Sold by VIRGINIA RETIREMENT SYSTEMS ET Al
Birinyi Associates Inc. Purchases New Position in Bristol Myers Squibb Company $BMY
Americana Partners LLC Acquires 46,008 Shares of Bristol Myers Squibb Company $BMY - Stock Observer
Bristol Myers Squibb Company $BMY Stock Sold by VIRGINIA RETIREMENT SYSTEMS ET Al - Stock Observer
BristolMyers news
Latest news
Show more
Global Market Review: Gold Volatility and Tech Stock Surge Amidst Economic Uncertainty
September CPI Data: Inflation Hurdles, Tariff Impacts, and Fed Rate Cut Expectations
Navigating the AI Boom: Strategies for Investors Amid Nvidia's Valuation Surge
